Holen Sie sich die Stockscreener-App
0.755
0.55%
-0.0042
Dyadic International Inc De Aktie (DYAI) Neueste Nachrichten
Skyline Corporate Communications Group, LLC Announces Dyadic Applied BioSolutions to Deliver a Live Presentation at the Skyline Signature Series™ on Wednesday, May 27 at 12:00 PM ET - GlobeNewswire Inc.
Dyadic International’s Earnings Call Shows Early Momentum - The Globe and Mail
Dyadic International Earnings Call Highlights Early Momentum - TipRanks
Earnings call transcript: Dyadic’s Q1 2026 revenue surges 182% despite EPS miss By Investing.com - Investing.com Australia
Dyadic International stock (US26746E1055): Shares climb after recent momentum - AD HOC NEWS
Dyadic International, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Dyadic International Q1 2026 revenue beats forecast, stock dips - Investing.com India
Earnings call transcript: Dyadic International Q1 2026 revenue beats forecast, stock dips By Investing.com - Investing.com India
Transcript: Dyadic International Q1 2026 Earnings Conference Call - Benzinga
Dyadic International (NASDAQ: DYAI) grows Q1 2026 revenue but flags going-concern risks - Stock Titan
Specialty Enzymes Market Overview, Emerging Trends, and Key Player Analysis - openPR.com
Analysis of Segments and Major Growth Areas in the Protein Hydrolysis Enzymes Market - openPR.com
Dyadic International stock (US26746E1055): Is its biotech platform strong enough to unlock new upsid - AD HOC NEWS
Dyadic International Stock: Biotechnology Innovator Focused on C1 Platform Amid Earnings Challenges - AD HOC NEWS
Dyadic International Earnings Call Highlights Commercial Pivot - TipRanks
Dyadic International, Inc.'s (NASDAQ:DYAI) Path To Profitability - simplywall.st
Dyadic International Q4 2025 Earnings Call Transcript - MarketBeat
Dyadic Applied BioSolutions Reports 2025 Financial Results, Commercial Launches, and Strategic Partnerships in Animal-Free Protein Production 12346 - Minichart
Dyadic Applied BioSolutions: Innovative Microbial Protein Production Platforms for Life Sciences, Food, and Industrial Markets - Minichart
Dyadic International Inc (DYAI) Q4 2025 Earnings Call Highlights: Navigating Transition with ... By GuruFocus - ca.investing.com
Dyadic International’s ability to sustain operations for the next year and avoid significant dilution depends on the effectiveness of its shift toward commercial strategies - Bitget
Dyadic (DYAI) Q4 2025 Earnings Call Transcript - theglobeandmail.com
Earnings call transcript: Dyadic Q4 2025 reveals revenue decline, stock up 3.32% - Investing.com Australia
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress - Yahoo Finance Singapore
Dyadic (NASDAQ: DYAI) posts lower 2025 revenue and wider annual net loss - Stock Titan
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - AOL.com
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices - GlobeNewswire
Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 - The Manila Times
Dyadic to detail full-year 2025 results in March 25 investor call - Stock Titan
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th - GlobeNewswire
Decliners Report: Can Dyadic International Inc outperform under higher oil pricesWeekly Market Outlook & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Dyadic International Establishes At-the-Market Equity Offering Program - The Globe and Mail
Dyadic and Fermbox Bio Launch First Product Under Expanded - GlobeNewswire
Dyadic Applied BioSolutions and Inzymes ApS Announce - GlobeNewswire
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following Achievement of Development Milestone - Yahoo Finance
Dyadic's Strategic Pivot: From Platform to Product - AD HOC NEWS
Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumin - Yahoo Finance
Segmentation, Major Trends, and Competitive Overview of the Industrial Biocatalysts Market - openPR.com
Enzyme Engineering Market to Get an Explosive Growth | Novozymes - openPR.com
Dyadic International (NASDAQ:DYAI) Stock Passes Below Fifty Day Moving Average – Should You Sell? - Defense World
Dyadic International (NASDAQ:DYAI) Share Price Crosses Below 50 Day Moving Average – Should You Sell? - Defense World
Dyadic International’s Tiny Stock, Big Volatility: Can DYAI’s Latest Rally Really Last? - AD HOC NEWS
Enzyme Engineering Market Set for Rapid Growth and Trend - openPR.com
Dyadic International Inc. (NASDAQ:DYAI) Short Interest Up 25.7% in December - Defense World
iAccess Alpha’s Virtual Best Ideas Winter Investment Conference December 9-10, 2025 - Ventura County Star
Dyadic International Amends Convertible Notes, Extends Maturity Timeline - TipRanks
Dyadic International receives Nasdaq notice for minimum bid price deficiency - Investing.com
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets - GlobeNewswire
Dyadic and Fermbox Bio Expand Strategic Collaboration to - GlobeNewswire
Analysis of Market Segmentation, Major Trends, and Competitive Dynamics in the Cellulase Market - openPR.com
Dyadic Applied BioSolutions Establishes Commercial - GlobeNewswire
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):